Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from iX Biopharma Ltd. ( (SG:42C) ).
iX Biopharma Ltd. held an Extraordinary General Meeting (EGM) on March 10, 2025, chaired by Mr. Eddy Lee Yip Hang. The meeting included the Board of Directors and shareholders, with voting conducted by poll. The meeting proceeded without any questions from shareholders, and all motions were proposed by the Chairman.
More about iX Biopharma Ltd.
iX Biopharma Ltd. is a company incorporated in Singapore, operating within the biopharmaceutical industry. The company focuses on developing and commercializing innovative therapies and products, leveraging its proprietary sublingual drug delivery technology.
YTD Price Performance: 5.00%
Average Trading Volume: 298,678
Technical Sentiment Signal: Buy
Current Market Cap: S$18.59M
See more data about 42C stock on TipRanks’ Stock Analysis page.